Terlipressin-induced ischemic skin necrosis: A rare association

American Journal of Case Reports

Volumn 15, Issue , 2014, Pages 476-479

  Banu Demet Ozel, Coskun ^a   Karaman, Ahmet ^a   Gorkem, Hasan ^a   Buğday, Irfan ^a   Poyrazoğlu, Orhan Kursad ^a   Senel, Fatma ^a  

^a Department of Gastroenterology Kayseri Training and Research Hospital ^*  (Turkey)

Author keywords

Liver Cirrhosis; Lypressin; Skin Diseases; Vascular

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; POTASSIUM; SODIUM; TERLIPRESSIN; LYPRESSIN; VASOCONSTRICTOR AGENT;

AGED; ARTICLE; BODY MASS; CASE REPORT; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECHOGRAPHY; ERYTHEMA; ESOPHAGUS VARICES BLEEDING; FATTY LIVER; HUMAN; HUMAN TISSUE; INTERNATIONAL NORMALIZED RATIO; MALE; MEAN CORPUSCULAR VOLUME; MEDICAL HISTORY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PROTHROMBIN TIME; SKIN BIOPSY; SKIN BRUISING; SKIN DEFECT; SKIN GRAFT; SKIN NECROSIS; SKIN SWELLING; SPLENOMEGALY; THROMBOCYTE COUNT; WOUND DRESSING; ANALOGS AND DERIVATIVES; BIOPSY; CHEMICALLY INDUCED; DIFFERENTIAL DIAGNOSIS; FOREARM; GASTROINTESTINAL HEMORRHAGE; NECROSIS; PATHOLOGY; SKIN DISEASE;

AGED; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FOREARM; GASTROINTESTINAL HEMORRHAGE; HUMANS; LYPRESSIN; MALE; NECROSIS; SKIN DISEASES; VASOCONSTRICTOR AGENTS;

EID: 84908387555     PISSN: None     EISSN: 19415923     Source Type: Journal    
DOI: 10.12659/AJCR.891084     Document Type: Article

References (18)

1. Krag A, Borup T, Moller S, Bendtsen F: Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome. Adv Ther, 2008; 25: 1105–40
2. Abraldes AJ, Dell’ Era A, Bosch J: Medical management of variceal bleeding in patients with cirrhosis. Can J Gastroenterol, 2004; 18: 109–13
3. Ortega R, Gines P, Uriz J et al: Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology, 2002; 36: 941–48
4. Moreau R, Durand F, Poynard T et al: Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology, 2002; 122: 923–30
5. Moller S, Hansen EF, Becker U et al: Central and systemic hemodynamic effects of Terlipressin in portal hypertensive patients. Liver, 2000; 20: 51–59
6. Krag A, Bendtsen F, Mortensen C et al: Effects of a single Terlipressin administration on cardiac function and perfusion in cirrhosis. Eur J Gastroenterol Hepatol, 2010; 22: 1085–92
7. Lee MY, Chu CS, Lee KT et al: Terlipressin-related acute myocardial infarction. Kaohsiung J Med Sci, 2004; 20: 604–8
8. Schmitt W, Wagner-Thiessen E, Lux G: Ischaemic colitis in a patient treated with Glypressin for bleeding oesophageal varices. Hepatogastroenterology, 1987; 34: 134–36
9. Lee HJ, Oh MJ. A case of peripheral gangrene and osteomyelitis secondary to terlipressin therapy in advanced liver disease. Clin Mol Hepatol, 2013; 19: 179–84
10. Fabrizi F, Dixit V, Martin P: Meta-analysis: terlipressin therapy for the hepatorenal syndrome. Aliment Pharmacol Ther, 2006; 24: 935–44
11. ®). Dermatology, 2009; 218: 334–37
12. Di Micoli A, Bracci E, Cappa FM et al: Terlipressin infusion induces ischemia of breast skin in a cirrhotic patient with hepatorenal syndrome. Dig liver Dis, 2008; 40: 304–5
13. Donnellan F, Cullen G, Hegarty JE, McCormick PA: Ischaemic complications of Glypressin in liver disease: a case series. Br J Clin Pharmacol, 2007; 64: 550–52
14. Efthymakis K, Massacesi C, Milano A et al: Acute esophageal necrosis: possible association with terlipressin. Endoscopy, 2014; 46(Suppl.1): E279–80
15. Vaccaro F, Giorgi A, Riggio O et al: Is spontaneous bacterial peritonitis an inducer of vasopressin analogue side-effects? A case report. Dig Liver Dis, 2003; 35: 503–6
16. Yefet E, Gershovich M, Farber E, Soboh S: Extensive epidermal necrosis due to terlipressin. Isr Med Assoc J, 2011; 13: 180–81
17. Halimi C, Bonnard P, Bernard B et al: Effect of terlipressin (Glypressin) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study. Eur J Gastroenterol Hepatol, 2002; 14: 153–58
18. Oh JE, Ha JS, Cho DH et al: A case of ischemic skin necrosis after glypressin therapy in liver cirrhosis. Korean J Gastroenterol, 2008; 51(6): 381–84